Medicare Likely Pays Twice for Hospice Drugs, Audit Says

Law360, New York (July 3, 2012, 7:26 PM EDT) -- A government watchdog said Tuesday that Medicare could be paying twice for prescription drugs for hospice patients, claiming that Medicare's prescription drug plan paid nearly $34 million for such drugs in 2009 that should have been covered under traditional Medicare insurance.

The prescription drug plan, known as Medicare Part D, paid for prescription analgesic, anti-nausea, laxative and anti-anxiety drugs, as well as prescription drugs used to treat chronic obstructive pulmonary disease and amyotrophic lateral sclerosis — drugs that likely should have been covered under per diem...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.